Balancing the costs with the benefits
Weight loss can mean better health and lower costs for plan sponsors and members alike. Investing in these expensive, but effective drugs is a balancing act – especially when more than half of the U.S. adult population is eligible for them. Get insights on how to manage costs for the most talked-about drugs in pharmacy.
![](/content/hub5/considerations-weight-loss-drugs/_jcr_content/root/container/container/column_half/col1/o4_adaptiveimage.png)
Weighty issue: How to contain anti-obesity drug costs
New anti-obesity medications are effective but expensive and more than half of U.S. adults are eligible for them. Members who reach a healthier weight are less likely to have other health complications, so their use is beneficial in the long run. But what about right now?
Plan sponsors need a game plan to balance the need for these drugs and contain the costs in their benefit plans.
![](/content/dam/o4-dam/images/professionals/pharmacies/tipping%20the%20scales-tiles-1080x720.jpg)
How to manage blockbuster anti-obesity drugs
![](/content/dam/optum4/resources/images/rx-podcast-weight-loss-speakers-tile.jpg)
GLP-1 agonists: A new class of weight loss medications
![](/content/dam/optum4/resources/images/mother-with-adult-daughter-1080x720.jpg)
Specialty and Weight Loss Webinar
![](/content/dam/o4-dam/images/professionals/pharmacies/pharmacy-insights-podcast-logo-1080x720-resource-library-tile.jpg)
Pharmacy Insights Podcast
![](/content/dam/o4-dam/images/professionals/pharmacies/2024-pharmacyinsightspodcast-sn3-ep1-youtube-1080x720-150.png)
The new drugs plan sponsors need to watch for
![](/content/dam/o4-dam/images/professionals/pharmacies/meeting-around-ipad-1080x720.jpg)